Family with sequence similarity 120 member A opposite strand (FAM120AOS)

FAM120AOS (Family with sequence similarity 120 member A opposite strand) encodes a protein whose molecular function and pathway involvement are currently uncharacterized[4][5][6]. It is a protein-coding gene mapped to chromosome 9, expressed in various tissues with notable expression data available from transcriptomic and proteomic analyses, especially in the brain[2][3]. Differences in FAM120AOS gene expression are statistically associated with glioma survival, but there is no evidence of receptor, enzyme, transporter activity, nor has it been implicated as a direct therapeutic target or biomarker with clinical utility[5]. Disease associations, beyond glioma prognosis, include cryptorchidism and gastroesophageal reflux, yet the mechanistic connections remain undefined[5]. There are no known interacting drugs, safety concerns, or defined molecular classifications for this protein, and functional studies are limited. If further characterization or experimentation emerges, the above properties should be re-evaluated. As of the latest available evidence, FAM120AOS is an uncharacterized protein-coding gene without established therapeutic target status[5][6].

Other names

FAM120AOSC9orf10OSFamily with sequence similarity 120A opposite strandFAM120A opposite strand proteinUncharacterized protein FAM120AOS[5][6]

None reported (No drugs target, and mechanism of action is unknown for this protein[5][6].)